The psychedelic industry has been abuzz with hope and optimism in recent years, especially as companies like Lykos Therapeutics have worked toward bringing innovative...
The fentanyl epidemic in the United States continues to devastate communities, with overdose deaths reaching catastrophic levels. As lawmakers grapple with the best course...
Acadia Healthcare (Nasdaq: ACHC), the largest behavioral health provider in the United States, has long been at the forefront of delivering comprehensive care across...
The substance use disorder (SUD) treatment industry is evolving rapidly, driven by a growing body of evidence that highlights the importance of offering evidence-based...
In a major move within the behavioral health space, T&R Recovery Group, a well-established provider of addiction and mental health treatment services, has acquired...
The need for comprehensive support in addressing substance use disorders (SUDs) among employees has never been greater. According to Robert Poznanovich, the Chief Business...